The case for putting genomic medicine to work
San Diego Union Tribune, August 16, 2010
Cardiologist Eric Topol, director of Scripps Translational Science Institute in La Jolla, is a leading advocate of using a rapidly expanding array of genetic tests to screen patients for drug complications. Topol says that most physicians don’t take advantage of this new medical advance. He explored the potential consequences for patients in a commentary published Wednesday in the journal Science Translational Medicine. He wrote this article explaining his views for the Union-Tribune.
Most Viewed
Most Emailed
- Primary Care Docs Average More Hospital Revenue Than Specialists
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- Building a Better Healthcare Board
- Q&A: Catholic Health Initiatives' New Senior VP for Capital Finance
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Quiet ORs Better for Patient Safety
- CMS Releases Hospital Pricing Data
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- Hospital Pricing Data Dump Won't Hurt You, Yet
- Telemedicine is Retail Health Clinics' Newest Tool
